StonvexLoading…
StonvexCore line items from CCC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $1.06B | $779.14M | $512.02M | $251.56M |
Operating Income | $93.84M | $43.75M | $13.77M | $-10.70M |
Net Income | $1.69M | $-6.43M | $-4.46M | $-17.42M |
EPS (Diluted) | $0.00 | $-0.01 | $-0.01 | $-0.03 |
Total Assets | $3.57B | $3.59B | $3.57B | $3.61B |
Total Liabilities | $1.79B | $1.46B | $1.43B | $1.43B |
Cash & Equivalents | $111.19M | $97.14M | $55.05M | $130.32M |
Free Cash Flow OCF − CapEx | $254.51M | $149.63M | $71.00M | $43.65M |
Shares Outstanding | 605.45M | 647.18M | 648.99M | 658.64M |